Literature DB >> 18809620

Pectic polysaccharides from Biophytum petersianum Klotzsch, and their activation of macrophages and dendritic cells.

Marit Inngjerdingen1, Kari T Inngjerdingen, Trushar R Patel, Stephanie Allen, Xinyong Chen, Bent Rolstad, Gordon A Morris, Stephen E Harding, Terje E Michaelsen, Drissa Diallo, Berit S Paulsen.   

Abstract

The Malian medicinal plant Biophytum petersianum Klotzsch (Oxalidaceae) is used as a treatment against various types of illnesses related to the immune system, such as joint pains, inflammations, fever, malaria, and wounds. A pectic polysaccharide obtained from a hot water extract of the aerial parts of B. petersianum has previously been reported to consist of arabinogalactans types I and II (AG-I and AG-II), probably linked to a rhamnogalacturonan backbone. We describe here further structural characteristics of the main polysaccharide fraction (BP1002) and fractions obtained by enzymatic degradations using endo-alpha-d-(1-->4)-polygalacturonase (BP1002-I to IV). The results indicate that in addition to previously reported structures, rhamnogalacturan type II and xylogalacturonan areas appear to be present in the pectic polymer isolated from the plant. Atomic force microscopy confirmed the presence of branched structures, as well as a polydisperse nature. We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes. We found that macrophages and dendritic cells were activated by BP1002 fractions, while there was little response of T cells, B cells, and NK cells. The enzymatic treatment of the BP1002 main fraction gave important information on the structure-activity relations. It seems that the presence of rhamnogalacturonan type I is important for the bioactivity, as the bioactivity decreases with the decreased amounts of rhamnose, galactose, and arabinose. The demonstration of bioactivity by the plant extracts might indicate the mechanisms behind the traditional medical use of the plant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809620     DOI: 10.1093/glycob/cwn090

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  6 in total

1.  Isolation, characterisation and complement fixation activity of acidic polysaccharides from Argemone mexicana used as antimalarials in Mali.

Authors:  Adama Dénou; Adiaratou Togola; Kari Tvete Inngjerdingen; Nastaran Moussavi; Frode Rise; Yuan Feng Zou; Dalen G Dafam; Elijah I Nep; Abubakar Ahmed; Taiwo E Alemika; Drissa Diallo; Rokia Sanogo; Berit Smestad Paulsen
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Activation of human T-helper/inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK)-cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin.

Authors:  Cheppail Ramachandran; Barry J Wilk; Arland Hotchkiss; Hoa Chau; Isaac Eliaz; Steven J Melnick
Journal:  BMC Complement Altern Med       Date:  2011-08-04       Impact factor: 3.659

Review 3.  Ethnopharmacology, Chemistry and Biological Properties of Four Malian Medicinal Plants.

Authors:  Karl Egil Malterud
Journal:  Plants (Basel)       Date:  2017-02-21

Review 4.  Modulation of dendritic cell immune functions by plant components.

Authors:  Alia M Aldahlawi
Journal:  J Microsc Ultrastruct       Date:  2016-01-08

5.  Bioactive flavone-C-glycosides of the African medicinal plant Biophytum umbraculum.

Authors:  Anh Thu Pham; Celine Nguyen; Karl Egil Malterud; Drissa Diallo; Helle Wangensteen
Journal:  Molecules       Date:  2013-08-26       Impact factor: 4.411

Review 6.  Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.

Authors:  Mengxun Zhang; Jiaqing Zhong; Yongai Xiong; Xun Song; Chenyang Li; Zhendan He
Journal:  Viruses       Date:  2021-06-28       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.